Cite
Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells.
MLA
Otsuka, Kenji, et al. “Anti-PD-1 Antibody Combined with Chemotherapy Suppresses the Growth of Mesothelioma by Reducing Myeloid-Derived Suppressor Cells.” Lung Cancer (01695002), vol. 146, Aug. 2020, pp. 86–96. EBSCOhost, https://doi.org/10.1016/j.lungcan.2020.05.023.
APA
Otsuka, K., Mitsuhashi, A., Goto, H., Hanibuchi, M., Koyama, K., Ogawa, H., Ogino, H., Saijo, A., Kozai, H., Yoneda, H., Tobiume, M., Kishuku, M., Ishizawa, K., & Nishioka, Y. (2020). Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells. Lung Cancer (01695002), 146, 86–96. https://doi.org/10.1016/j.lungcan.2020.05.023
Chicago
Otsuka, Kenji, Atsushi Mitsuhashi, Hisatsugu Goto, Masaki Hanibuchi, Kazuya Koyama, Hirohisa Ogawa, Hirokazu Ogino, et al. 2020. “Anti-PD-1 Antibody Combined with Chemotherapy Suppresses the Growth of Mesothelioma by Reducing Myeloid-Derived Suppressor Cells.” Lung Cancer (01695002) 146 (August): 86–96. doi:10.1016/j.lungcan.2020.05.023.